Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 03/02/2011
PIL Androcur

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/02/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 31/01/2011 and displayed until 03/02/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
  • Extra statutory information
Updated on 17/06/2010 and displayed until 31/01/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 09/06/2010 and displayed until 17/06/2010
Reasons for adding or updating:
  • Change to dosage and administration
  • Change to date of revision
Updated on 10/09/2009 and displayed until 09/06/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 17/08/2009 and displayed until 10/09/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 04/06/2008 and displayed until 17/08/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change of licence holder
  • Change to Marketing Authorisation Holder
  • Change to MA holder contact details
Updated on 22/09/2006 and displayed until 04/06/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 03/09/2004 and displayed until 22/09/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 31/08/2004 and displayed until 03/09/2004
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to date of revision
  • Change to, or new, use for medicine
Updated on 15/07/2002 and displayed until 31/08/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 24/07/2001 and displayed until 15/07/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 19/07/2000 and displayed until 24/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  cyproterone acetate